HomeProductsBuilding BlocksHeterocyclic ScaffoldsAliphatic HeterocyclesDideoxycytidine
Chemical structure of CAS 7481-89-2

Dideoxycytidine

In Stock•Starting at $8 for 1 mg•Purity ≥ 96%
CAS No.7481-89-2
MDL No.MFCD00012188
MFC9H13N3O3
MW211.22
InChI KeyWREGKURFCTUGRC-POYBYMJQSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg99%$8In Stock
10 mg99%$9In Stock
50 mg96%$21In Stock
100 mg98%$24In Stock
250 mg98%$32In Stock
1 g98%$113In Stock
5 g98%$490In Stock
25 g96%$1683In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Zalcitabine is a pyrimidine 2',3'-dideoxyribonucleoside with cytosine as the nucleobase. It functions as an antiviral drug, an antimetabolite, and an HIV-1 reverse transcriptase inhibitor.

CAS No.7481-89-2
Product NameDideoxycytidine

Associated Conditions

viral disease·HIV infection
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Activities of masked 2',3'-dideoxynucleoside monophosphate derivatives against human immunodeficiency virus in resting macrophages.

Antimicrobial agents and chemotherapy • Vol. 44, Issue 1 • 2000
PMID: 10602742PMC: PMC89647DOI: 10.1128/AAC.44.1.173-177.2000

Antiviral properties of a series of 1,6-naphthyridine and 7, 8-dihydroisoquinoline derivatives exhibiting potent activity against human cytomegalovirus.

Antimicrobial agents and chemotherapy • Vol. 44, Issue 4 • 2000
PMID: 10722493PMC: PMC89794DOI: 10.1128/AAC.44.4.929-937.2000

Selection and characterization of human immunodeficiency virus type 1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thio-5-fluorocytidine.

Antimicrobial agents and chemotherapy • Vol. 44, Issue 5 • 2000
PMID: 10770740PMC: PMC89833DOI: 10.1128/AAC.44.5.1127-1131.2000

Effect of nucleoside analogs and non-nucleoside inhibitors of HIV-1 reverse transcriptase on cell-free virions.

Archives of virology • Vol. 144, Issue 3 • 1999
PMID: 10226617DOI: 10.1007/s007050050522

Documentation

Similar Products